78. 下垂体前葉機能低下症 Hypopituitarism Clinical trials / Disease details


臨床試験数 : 494 薬物数 : 385 - (DrugBank : 49) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 100

  
8 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03274973
(ClinicalTrials.gov)
May 14, 201829/8/2017Study to Assess Long-term Effectiveness of Zomacton® and Treatment Adherence in Patients With Growth Hormone Deficiency or Ullrich-Turner SyndromeA Prospective Non-Interventional Study to Assess Long-term Effectiveness of Zomacton® and Factors Affecting Adherence in Patients With Growth Hormone Deficiency or Growth Retardation Due to Ullrich-Turner SyndromeGrowth DisordersDrug: ZomactonFerring PharmaceuticalsNULLTerminatedN/A18 YearsAll4Germany
2NCT02018172
(ClinicalTrials.gov)
July 201417/12/2013Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X DeviceGrowth Hormone Deficiency;Turner's SyndromeDrug: somatropinFerring PharmaceuticalsNULLTerminatedN/AN/ABoth3N/AFrance
3EUCTR2012-005066-36-NL
(EUCTR)
15/05/201323/01/2013To investigate the effect of different doses of Growth Hormone treatment on the risk of developing cardiovascular diseases in patients with growth hormone deficiencyEffect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentration - GH and cardiovascular risk factors Growth hormone deficiency;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]Trade Name: Genotropin
Trade Name: Norditropin
Trade Name: Humatrope
Trade Name: Zomacton
VU University Medical CenterNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Netherlands
4NCT01731028
(ClinicalTrials.gov)
January 201316/11/2012Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton®Non-interventional, Observational Study of the Application of Zomacton® in the Treatment of Growth Hormone Deficiency in Routine Clinical PracticeGrowth Hormone DeficiencyDrug: SomatropinFerring PharmaceuticalsNULLWithdrawn3 Years18 YearsBoth0N/ANULL
5NCT00884000
(ClinicalTrials.gov)
January 201017/4/2009A Study of Zomacton in Children With Growth Hormone DeficiencyA Randomised, Open-label, Parallel-group, Multi-centre Trial to Compare the Efficacy and Safety for 12 Months of Zomacton to Genotropin in Children With Idiopathic Growth Hormone DeficiencyGrowth Hormone DeficiencyDrug: Genotropin;Drug: ZomactonFerring PharmaceuticalsNULLCompleted3 Years11 YearsBoth165Phase 3Hungary;India;Israel;Poland;Romania;Russian Federation;Ukraine
6EUCTR2008-004849-28-HU
(EUCTR)
09/07/200903/06/2009A randomised, open-label, parallel-group, multi-centre trial comparing the efficacy and safety of 12 months treatment with one daily dose of ZOMACTON® to one daily dose of GENOTROPIN® in the treatment of children with idiopathic growth hormone deficiency - Idiopathic growth hormone deficiency.
MedDRA version: 9.1;Level: LLT;Classification code 10056438;Term: Growth hormone deficiency
Trade Name: Zomacton 10 mg/ml
INN or Proposed INN: Somatropin
Trade Name: Genotropin 12 mg/ml
INN or Proposed INN: Somatropin
Ferring Pharmaceuticals A/SNULLNot RecruitingFemale: yes
Male: yes
138Hungary
7NCT01365351
(ClinicalTrials.gov)
December 1, 20071/6/2011Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTONNon-interventional Study With ZOMACTON in Children With Growth Hormone DeficiencyGrowth Hormone DeficiencyOther: Growth hormoneFerring PharmaceuticalsFerring Arzneimittel GmbHCompletedN/AN/AAll1034N/AGermany
8NCT01306357
(ClinicalTrials.gov)
September 200728/2/2011Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free DeviceEvaluation De L'Observance Globale Et De La Duree De Traitement Par Zomacton® Avec Le Stylo Transjecteur Zomajet® Etude Pharmaco-Epidemiologique Observationnelle Longitudinale ProspectiveTurner's Syndrome;Human Growth Hormone DeficiencyDrug: SomatropinFerring PharmaceuticalsNULLCompletedN/AN/ABoth87N/AFrance